[123I]-mIBG and [18F]-FDOPA differential uptake in the follow-up of neonatal neuroblastoma [PDF]
Single photon emission computed tomography (SPECT/CT) using meta-iodobenzylguanidine (mIBG) is currently recommended in pediatric clinical guidelines for assessing neuroblastoma.
Agathe Edet-Sanson +5 more
doaj +2 more sources
Impact of mediastinal, liver and lung I-metaiodobenzylguanidine (I-MIBG) washout on calculated I-MIBG myocardial washout [PDF]
PURPOSE: In planar (123)I-metaiodobenzylguanidine ((123)I-MIBG) myocardial imaging mediastinum (M) activity is often used as a background correction in calculating "washout" (WO).
Hein J. Verberne +4 more
core +14 more sources
On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases. [PDF]
Abnormal cardiac uptake of 123I-metaiodobenzylguanidine (123I-MIBG) is a diagnostic marker of Lewy body diseases (LBDs), e.g., Parkinson's disease (PD) and dementia with Lewy bodies (DLB).
Hayato Odagiri +11 more
doaj +1 more source
Cardiac I-metaiodobenzylguanidine Scintigraphy in a Patient with Familial Parkinsonism with Gene Mutation [PDF]
A decreased cardiac 123I-metaiodobenzylguanidine (123I-MIBG) uptake has been used as a powerful tool to identify Lewy body disease, such as idiopathic parkinson’s disease (IPD).
Young-Do Kim +4 more
doaj +1 more source
Clinical experience with F-fluorodeoxyglucose positron emission tomography and I-metaiodobenzylguanine scintigraphy in pediatric neuroblastoma: complementary roles in follow-up of patients [PDF]
PurposeTo evaluate the potential utility of 123I-metaiodobenzylguanine (123I-MIBG) scintigraphy and 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) for the detection of primary and metastatic lesions in pediatric neuroblastoma (NBL ...
Tae Young Gil +4 more
doaj +1 more source
Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family [PDF]
Head and neck paragangliomas are the most common clinical features of familial paraganglioma syndrome type 1 caused by succinate dehydrogenase complex subunit D (SDHD) mutation. The clinical management of this syndrome is still unclear.
Cantisani, Vito +12 more
core +1 more source
Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease [PDF]
Objective(s): We recently developed a new uptake index method for123I-metaiodobenzylguanidine (123I-MIBG) heart uptake measurements by using planarimages (radioisotope angiography and planar image) for the diagnosis of Lewy bodydisease (LBD), including ...
Yoshito Kamiya +5 more
doaj +1 more source
Uptake index of 123I-metaiodobenzylguanidine myocardial scintigraphy for diagnosing Lewy body disease [PDF]
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used to evaluate cardiac sympathetic denervation in Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB).
Yoshito Kamiya +5 more
doaj +1 more source
Imágenes de inervación miocárdica: MIBG en práctica clínica
La 123I-metayodobencilguanidina (MIBG) es un análogo de norepinefrina radiomarcado que se puede usar para investigar la inervación simpática del miocardio. La gammagrafía con 123I-MIBG se ha investigado con interés en muchos contextos patológicos.
Alberto Aimo , Alessia Gimelli
doaj +1 more source
Previous reports have found evidence that the lung uptake of iodine-123-metaiodobenzylguanidine (123I-MIBG) represents pulmonary vascular endothelial function.
Kenjuro Higo, MDPhD +6 more
doaj +1 more source

